parkinson's disease triple agonist glp-1 gip glucagon clinical trial Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Glucagon-like peptide-1 - Wikipedia
Description
A comprehensive phase 3 program is ongoing to evaluate efficacy, safety, and cardiovascular/renal outcomes in people with obesity and/or T2D
Discover clinical trial results and which GLP-1 medication may be right for you.
Importantly, increasing the endogenous production of GLP-1 by different mechanisms or by increasing the number of intestinal L-cells that tend to produce this hormone may be another effective therapeutic approach to managing T2DM
Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar
A reminder that their story doesnt start in Hollywood
